Aug 29, 2023 08:01AM
Aug 29, 2023 08:00AM
Aug 3, 2023 07:30AM
May 4, 2023 04:30PM
Apr 17, 2023 08:01AM
Apr 17, 2023 08:00AM
Mar 30, 2023 08:07AM Axcella Therapeutics (AXLA) Reports Q4, Provides Business Update
Mar 30, 2023 08:00AM
Feb 15, 2023 04:13PM
Feb 15, 2023 04:10PM
Jan 23, 2023 04:15PM
Jan 23, 2023 04:15PM
Dec 14, 2022 08:01PM
Nov 1, 2022 07:00AM Axcella Reports Third Quarter Financial Results and Provides Business Update
Oct 13, 2022 08:03AM
Oct 13, 2022 08:00AM
Sep 29, 2022 06:11AM
Sep 29, 2022 06:00AM
Aug 12, 2022 07:30AM
Aug 2, 2022 06:00AM
May 26, 2022 07:00AM Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio
May 5, 2022 07:00AM
Mar 30, 2022 07:32AM
Mar 30, 2022 07:32AM
Feb 28, 2022 09:00AM
Feb 14, 2022 07:58AM
Feb 14, 2022 07:58AM
Feb 7, 2022 07:55AM Axcella Therapeutics (AXLA) Announces Appointment of New CFO
Feb 7, 2022 07:55AM
Jan 6, 2022 07:58AM
Jan 6, 2022 07:58AM
Dec 16, 2021 07:28AM
Dec 6, 2021 07:50AM
Dec 6, 2021 07:50AM
Nov 10, 2021 07:59AM Axcella Health (AXLA) Provides Updates on Long COVID, OHE and NASH Clinical Trials; Reports Q3 Results
Nov 10, 2021 07:58AM
Oct 26, 2021 06:58AM
Oct 26, 2021 06:58AM
Oct 19, 2021 07:58AM
Aug 16, 2021 07:59AM
Aug 16, 2021 07:58AM
Jul 29, 2021 07:28AM Axcella Reports Second Quarter Financial Results and Provides Business Update
Jul 6, 2021 09:30AM
Jul 6, 2021 06:07AM
Jun 30, 2021 07:28AM
May 24, 2021 07:28AM
May 24, 2021 07:28AM
May 11, 2021 07:28AM
May 11, 2021 07:28AM Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125
May 6, 2021 07:28AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All